Barclays’s Galectin Therapeutics GALT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-9,326
Closed -$12K 4415
2025
Q1
$12K Sell
9,326
-45,308
-83% -$58.3K ﹤0.01% 4121
2024
Q4
$71K Buy
54,634
+26,047
+91% +$33.9K ﹤0.01% 3864
2024
Q3
$79K Buy
28,587
+21,598
+309% +$59.7K ﹤0.01% 3799
2024
Q2
$15K Buy
+6,989
New +$15K ﹤0.01% 3938
2021
Q4
Sell
-2,407
Closed -$9K 3463
2021
Q3
$9K Sell
2,407
-4,200
-64% -$15.7K ﹤0.01% 3761
2021
Q2
$21K Sell
6,607
-24,487
-79% -$77.8K ﹤0.01% 3704
2021
Q1
$68K Buy
31,094
+19,088
+159% +$41.7K ﹤0.01% 3469
2020
Q4
$27K Sell
12,006
-5,274
-31% -$11.9K ﹤0.01% 3337
2020
Q3
$46K Sell
17,280
-3,771
-18% -$10K ﹤0.01% 3326
2020
Q2
$64K Buy
21,051
+7,669
+57% +$23.3K ﹤0.01% 3309
2020
Q1
$27K Sell
13,382
-26,678
-67% -$53.8K ﹤0.01% 3305
2019
Q4
$115K Buy
40,060
+20,188
+102% +$58K ﹤0.01% 3405
2019
Q3
$72K Sell
19,872
-916
-4% -$3.32K ﹤0.01% 3560
2019
Q2
$86K Sell
20,788
-111,603
-84% -$462K ﹤0.01% 3658
2019
Q1
$677K Sell
132,391
-42,212
-24% -$216K ﹤0.01% 2431
2018
Q4
$599K Buy
174,603
+168,393
+2,712% +$578K ﹤0.01% 2159
2018
Q3
$37K Buy
6,210
+3,016
+94% +$18K ﹤0.01% 3817
2018
Q2
$20K Sell
3,194
-16,929
-84% -$106K ﹤0.01% 3642
2018
Q1
$96K Buy
+20,123
New +$96K ﹤0.01% 3186
2015
Q2
Sell
-574
Closed -$1K 4116
2015
Q1
$1K Sell
574
-837
-59% -$1.46K ﹤0.01% 3983
2014
Q4
$4K Buy
1,411
+1,224
+655% +$3.47K ﹤0.01% 3955
2014
Q3
$1K Sell
187
-208
-53% -$1.11K ﹤0.01% 4208
2014
Q2
$5K Buy
395
+326
+472% +$4.13K ﹤0.01% 3883
2014
Q1
$1K Sell
69
-3,231
-98% -$46.8K ﹤0.01% 4202
2013
Q4
$26K Buy
3,300
+2,800
+560% +$22.1K ﹤0.01% 3637
2013
Q3
$5K Buy
+500
New +$5K ﹤0.01% 3786